Skip to main content

Table 3 Standard curve performance of reduced hIL-33 iPCR

From: Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

Nominal conc (pg/mL)

Measured mean conc (pg/mL)

% Recovery

%CV

20

19.06

95.3

1.5

10

9.93

99.3

1.2

5

5.18

103.6

1.2

2.5

2.32

92.9

1.3

1.25

1.24

98.9

1.5

0.63

0.63

101.0

0.9

0.31

0.31

98.2

1.2

0.16

0.15

97.3

0.9

0.078

0.074

94.8

1.1

  1. n = 6 independent assay runs. LLOQ = 0.078 pg/mL, ULOQ = 20 pg/mL